Diseño de la portada del título Drugs and the FDA

Drugs and the FDA

Safety, Efficacy, and the Public's Trust

Muestra

Escúchalo ahora gratis con tu suscripción a Audible

Prueba gratis durante 30 días
Después de los 30 días, 9,99 €/mes. Cancela cuando quieras
Disfruta de forma ilimitada de este título y de una colección con 90.000 más.
Escucha cuando y donde quieras, incluso sin conexión
Sin compromiso. Cancela gratis cuando quieras.

Drugs and the FDA

De: Mikkael A. Sekeres
Narrado por: Mike Lenz
Prueba gratis durante 30 días

Después de los 30 días, 9,99 €/mes. Cancela cuando quieras.

Compra ahora por 18,99 €

Compra ahora por 18,99 €

Confirma la compra
Paga utilizando la tarjeta terminada en
Al confirmar tu compra, aceptas las Condiciones de Uso de Audible y nos autorizas a realizar el cobro mediante los métodos de pago por ti designados. Por favor revisa nuestra Política de Privacidad, Política de cookies y Aviso sobre anuncios basados en intereses
Cancelar

Acerca de este título

Food and Drug Administration approval for COVID-19 vaccines and the controversial Alzheimer's drug Aduhelm made headlines, but few of us know much about how the agency does its work. Why is the FDA the ultimate United States authority on a drug's safety and efficacy? In Drugs and the FDA, Mikkael Sekeres—a leading oncologist and former chair of the FDA's cancer drug advisory committee—tells the story of how the FDA became the most trusted regulatory agency in the world. It took a series of tragedies and health crises, as well as patient advocacy, for the government to take responsibility for ensuring the efficacy and safety of drugs and medical devices.

Before the FDA existed, drug makers could hawk any potion, claim treatment of any ailment, and make any promise on a label. But then, throughout the twentieth century, the government was forced to take action when children were poisoned by contaminated diphtheria and smallpox vaccines, an early antibiotic contained antifreeze, a drug prescribed for morning sickness in pregnancy caused babies to be born disfigured, and access to AIDS drugs was limited to a few clinical trials while thousands died. Sekeres describes all these events against the backdrop of the contentious 2011 hearings on the breast cancer drug Avastin, in which he participated as a panel member.

©2022 Mikkael A. Sekeres (P)2023 Tantor
Legislación Medicina y sector de la salud

Lo que los oyentes dicen sobre Drugs and the FDA

Valoración media de los usuarios. Solo los usuarios que hayan escuchado el título pueden escribir reseñas.

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.